Jeffrey M. Jonas is CEO & President at Sage Therapeutics, Inc. (SAGE). They have made 12 open-market trades across 1 company since 2014, most recently 2024-03-18.
CIK 0001042021
3 open-market purchases totalling $601K since 2014, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRTX | SELL · 10b5-1 | 2023-09-01 | 2023-09-05 | $187.96 | $5.1M | -4.0% | -8.9% | +4.8% |
| KRTX | SELL · 10b5-1 | 2023-08-01 | 2023-08-02 | $195.72 | $5.2M | -2.7% | +1.3% | -10.5% |
| KRTX | SELL · 10b5-1 | 2023-07-03 | 2023-07-05 | $216.42 | $6.0M | -1.8% | -13.1% | -24.6% |
| SAGE | SELL | 2023-02-10 | 2023-02-10 | $44.61 | $1.0M | -7.1% | -3.1% | +17.5% |
| SAGE | BUY | 2019-12-09 | 2019-12-10 | $64.20 | $482K | +15.7% | +17.1% | -31.0% |
| SAGE | SELL | 2019-05-29 | 2019-05-29 | $170.94 | $150K | -0.9% | +5.1% | -4.5% |
| SAGE | SELL | 2019-05-28 | 2019-05-29 | $174.83 | $14.8M | -0.9% | +5.1% | -4.5% |
| SAGE | SELL | 2019-05-28 | 2019-05-29 | $174.79 | $29.9M | -0.9% | +5.1% | -4.5% |
| SAGE | SELL | 2019-05-24 | 2019-05-24 | $175.02 | $6.9M | -0.6% | +0.9% | -3.5% |
| SAGE | SELL | 2019-05-23 | 2019-05-24 | $174.63 | $8.6M | -0.6% | +0.9% | -3.5% |
| SAGE | SELL | 2019-05-23 | 2019-05-24 | $174.75 | $16.5M | -0.6% | +0.9% | -3.5% |
| SAGE | SELL | 2017-12-21 | 2017-12-22 | $157.31 | $35.1M | +2.6% | +2.2% | -3.0% |
| SAGE | SELL | 2017-12-21 | 2017-12-22 | $157.45 | $33.1M | +2.6% | +2.2% | -3.0% |
| SAGE | BUY | 2015-12-31 | 2016-01-07 | $49.56 | $11K | -17.5% | -38.4% | -19.0% |
| SAGE | SELL · 10b5-1 | 2015-07-23 | 2015-07-24 | $76.79 | $230K | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-06-15 | 2015-06-17 | $77.36 | $15.4M | -30.6% | -2.1% | -2.1% |
| SAGE | BUY | 2014-07-23 | 2014-07-23 | $18.00 | $108K | -30.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.